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Abstract
Introduction: Tenosynovial giant cell tumors are benign tumors of uncertain pathogenesis. They
occur in the joints, tendons and synovial bursas. Due to a high recurrence rate of up to 50%, some
authors call a giant cell tumor a semimalignant tumor. To date, less than 10 cases of tenosynovial
giant cell tumor of the ankle have been published in the international medical literature.
Case presentation: In this case report, we present two patients with localized tumors that were
detected accidentally after the occurrence of ankle sprains with persisting pain in the joint. The
tumors were resected by open marginal surgery and regular follow-up examinations were carried
out.
Conclusions: We present an unusual occurrence of a tumor along with a possible follow-up
strategy, which has not been previously discussed in the international literature.
Introduction
A tenosynovial giant cell tumor (TGCT) is a benign tumor
of uncertain pathogenesis. It occurs in the joints, tendons
and synovial bursas. First described in the international
literature by Jaffe et al. [1] in 1941, it has been given dif-
ferent names including nodular tenosynovitis or (pig-
mented) villonodular synovitis or tenosynovitis, and
bursitis [1-5]. TGCT may be either localized or diffused.
The localized type of the tumor is most commonly found
in finger joints while subtypes of diffuse-type TGCT may
be distinguished as intra-articular and extra-articular. The
lesion may appear anywhere in the synovium, but in 80%
to 90% of cases, it occurs in the hand joints, and infre-
quently in the knee and foot joints [6]. Due to the high
recurrence rate of up to 50%, a correct classification of the
tumor is essential. As a result of this, and also of the pos-
sible malignant degeneration of the tumor, some call the
TGCT a semimalignant tumor [5-8],.
There has been no indication so far that specific age
groups or gender have a higher incidence rate of acquiring
the tumor. Studies described by Somerhausen et al. show
28 cases of the tumor occurring among women and 22
such cases occurring in men, which clearly shows no sig-
nificant difference in incidence (binomial test, p = 0.479).
Furthermore, some authors assume that the lesions are
caused by an unknown agent while others consider them
to be neoplastic [9,10,2].
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by a reactive proliferation of histiocytic cells in the reticu-
loendothelial system. After phagocytosis of erythrocytes
the cells undergo a transformation into hemosiderin-
laden macrophages that merge into giant cells [10].
To date, less than 10 cases of TGCT of the ankle have been




A 30-year-old Caucasian man suffered from a distortion of
his right ankle seven months prior to presentation. The
incident happened when he was at work. Due to persist-
ing pain in his joint he first saw a general practitioner. An
X-ray image of the patient's right ankle showed no patho-
logical findings. The joint was immobilized for six weeks
in a plaster cast, which was then followed by physical ther-
apy. Six months after the therapy, however, the patient
still suffered pain in his ankle with no sign of any
improvement. A magnetic resonance imaging (MRI) scan
revealed an unknown but well-circumscribed localized
tumor at the ventral part of the ankle, coupled with focal
bulging and erosion of the tibia and talus (Figure 1). The
MRI detected no damage to the fibular collateral liga-
ments. On examination, about thirteen months after
trauma of the ankle, tenderness to pressure was found at
the ventral aspect of the right ankle next to the medial
malleolus. A dorsal extension of the ankle was very pain-
ful. The collateral ligaments showed no insufficiency and
a new X-ray still did not show any conspicuous findings.
An ultrasound investigation showed a solid, homogene-
ous hypoechoic mass measuring 3.5 × 2.5 × 2 cm. It was
not clear whether the tumor was directly connected to the
joint. An impingement syndrome of the right ankle
caused by a synovial hypertrophy was diagnosed preoper-
atively.
The tumor was resected through a ventral access. A brown-
ish yellow tumor that was mainly solid was found during
surgery. The tumor showed adhesions to the capsular of
the patient's ankle and the complete tumor was treated
with marginal resection (Figure 2A). A small hypertrophy
of the cartilage below the tumor was also removed. How-
ever, the complete cartilage of the joint was not damaged.
Microscopically, the tumor was partially encapsulated and
composed of round to polygonal cells. Some were spindle
cells and some were multinucleated giant cells (Figure
2B). The diagnosis of localized tenosynovial giant cell
tumor of the tendon sheath was confirmed on histopa-
thology. Results of special stains indicated the presence of
iron in both mononuclear and multinucleated giant cells
in cytologic and histologic preparations.
During follow-up the patient presented no complications.
Investigations three, six, 12, and 24, as well as the MRI
scan conducted 24 months after surgery, showed no recur-
rence of the TGCT (Figure 3). To this day the patient is free
of any symptoms.
Case report 2
A 29-year-old Caucasian woman originally suffered from
a distortion of her upper left ankle more than six years
prior to presentation. The patient developed a chronic
instability with recurrent distortions following the con-
servative treatment she underwent. After the most recent
distortion, a computed tomography (CT) scan revealed
substantial cystic lesions in the trochlea of her talus, syn-
ovial reaction with foreign tissue in the neighboring cap-
Sagittal T1-weighted spin-echo MRI of the right ankle show-ing a well delinea gia t cell tumor ant rior o the ankle ( rro )Fi ure 1
Sagittal T1-weighted spin-echo MRI of the right ankle 
showing a well delineated giant cell tumor anterior 
to the ankle (arrow).
Macroscopic and histological images of the TGCTFigure 2
Macroscopic and histological images of the TGCT. 
(A) A macroscopic image of the tumor after resection. (B) 
Histological findings using hematoxylin and eosin staining of a 
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synovial membrane. On physical examination upon
admission, however, the patient's gait pattern and mobil-
ity showed no abnormalities.
A lateral instability caused by ligament insufficiency was
consequently found. Lateral stress views showed a 15-
degree clear space widening and a talar shift of more than
10 mm.
The patient underwent an arthroscopy of the left ankle.
The tumor was resected via open surgery. The articular sur-
face of the talus and the distal tibia showed an extensive
four-degree defect of the cartilage. Arthrotomy showed a
brownish yellow tumor that was mainly solid attached to
the ventral synovial tissue. This was entirely removed
through a marginal resection. Additionally, these defects
were smoothened and microfractured. The ligamental
structures were not rebuilt because of advanced arthrosis
of the patient's upper ankle. No complications occurred
after the operation and the histological analysis identified
the tumor as a localized TGCT.
Follow-up examinations after three, six, 12 and 24
months showed no indication of a recurrence of the
tumor. An MRI scan 24 months after the operation
showed no new tumor growth. However, a recurring pain
in the patient's upper left ankle made another arthroscopy
necessary. This procedure showed that a fibrocartilage had
formed but no hypertrophic synovia was found to be
present.
Discussion
TGCT is a tumor that surgeons or orthopedics rarely diag-
nose. The international literature cites less than 10 cases of
TGCT in the ankle. An important characteristic of the
tumor is its slow growth, which leads to its usual diagno-
sis only by coincidence. Differential diagnosis has to take
a number of other tumors into account, including lipoma,
ganglia or fibromas. Prior to an operation, it is usually
very difficult to distinguish whether the tumor is benign
or malignant.
In the first case discussed in this report, the patient was
suffering from pain caused by an impingement syndrome
at the ventral part of his ankle. The resection of the TGCT
left the patient with no discomfort or pain.
In the second case, recurrent distortions led to an
advanced arthrosis in the patient's upper ankle. The
patient continued to feel discomfort even after the tumor
had been removed; hence, the tumor was unlikely to have
caused the symptoms she experienced. Clearly, the tumor
in this patient was found only by coincidence. Ligament
augmentation was not performed because of advanced
arthrosis in the patient's upper ankle.
The therapy of choice consists of a resection of the tumor
that follows the basic principles of oncology since the
tumor has to be regarded as malignant until proven oth-
erwise [6,10-13]. A neoadjuvant or adjuvant therapy is not
usually necessary [6].
The etiology of TGCT has been discussed rather controver-
sially in the literature. Our patients presented with persist-
ing pain in the joint after they experienced certain
traumas. The tumors were only detected accidentally. In
both cases, however, it remains unclear whether distor-
tion or chronic irritation of the upper ankle may have
caused or influenced the development of TGCT.
Conclusions
Since they are rather rare, soft tissue tumors are often
either taken lightly or misdiagnosed all together [3,13]. It
is thus important to consider the presence of this type of
tumor once common conditions such as trauma and
degeneration have already been excluded.
In addition, regular follow-ups are vital due to the high
recurrence rate of the tumor in up to 50% of documented
cases. MRI is a very suitable technology for diagnosing
and identifying a tumor. In the literature, however, no
advice is given as to when the follow-up should take place.
The cases discussed above were periodically reanalyzed
clinically and with the use of sonography at three, six,
nine and 12 months. From then on the patients were
advised to attend an annual follow-up for five years after-
An image of the follow-up MRI of the right ankle 24 months after surgeryFigure 3
An image of the follow-up MRI of the right ankle 24 
months after surgery. A sagittal T1-weighted spin-echo 
MR image showing subcutaneous scars anterior to the ankle.Page 3 of 4
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wards. Another MRI will be done after two and five years.
If the sonographic analysis shows an indication for a
recurrence or if it shows unclear diagnostic findings, an
MRI examination should also be performed.
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